Evidence map›Paper›PMID 37127284›Full record

ArticleACS applied materials & interfaces2023

Neural Stem Cells as Carriers of Nucleoside-Conjugated Nanogels: A New Approach toward Cell-Mediated Delivery.

Agnieszka Morgenroth, Fatima Baazaoui, Aisa Hosseinnejad, Laura Schäfer, Andreas Vogg, Smriti Singh, Felix M Mottaghy

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Agnieszka MorgenrothDepartment of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-5712-6881
Fatima BaazaouiDepartment of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany.
Aisa HosseinnejadDWI - Leibniz-Institute for Interactive Materials, RWTH Aachen University, 52074 Aachen, Germany.
Laura SchäferDepartment of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany.
Andreas VoggDepartment of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany.
Smriti SinghDWI - Leibniz-Institute for Interactive Materials, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-2164-9912
Felix M MottaghyDepartment of Nuclear Medicine, RWTH Aachen University, 52074 Aachen, Germany.ORCID 0000-0002-7212-6521

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neural stem cells (NSCs) present attractive natural drug delivery systems (DDSs). Their migratory potential enables crossing of the blood-brain barrier and efficient and selective accumulation near malignant cells. Here, we present the potential of NSCs as DDSs for nucleoside analogue-conjugated nanogels (NGs). Two different approaches were investigated: the intracellular loading and extracellular cell surface decoration with NGs. For both designs, the tumor-specific migratory potentials of NSCs remained unchanged; however, the intracellular loading showed a shorter NG retention. The cell surface decoration protocol yielded a high loading capacity of 100% after 1 h and a prolonged drug retention. A redox-sensitive linker between NGs and the nucleoside analogue 5-ethynyl-2'-deoxycytidine (EdC) allowed a tumor environment-specific drug release and its efficient and preferential incorporation into the DNA of the tumor cells. Interestingly, the tumor-trafficking potentials of NSCs were significantly potentiated by irradiation of tumor cells. In conclusion, this study indicates the potentials of cell surface-decorated NSCs as DDSs for tumor-specific release, cellular uptake, and incorporation of EdC into DNA.

Indexed as

NeoplasmsNeural Stem CellsDrug Delivery SystemsHumansNanogelsNucleosidesNanogelsNucleosidesdrug deliveryglioblastomananogelsneural stem cellsnucleoside

Identifiers

PMID37127284
PMCPMC10176478

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.